
A company hid evidence that half of the popular diet-drug combination fen-phen caused serious heart problems, a lawyer for a woman suing American Home Products Corp. for $110 million said Wednesday.
Lawyers representing millions of people who used the diet drug combination fen-phen are negotiating a national settlement of health claims against the manufacturer, American Home Products Corp., a lawyer confirmed today.
Through its Wyeth-Ayerst Laboratories subsidiary, American Home Products marketed fenfluramine -- half of the fen-phen combination -- and Redux, a similar product.
The lawsuit asserts that American Home Products Corp. underreported the instances of pulmonary hypertension as a result of using fenfluramine, the fen part of the drug combination.
The two fen drugs sold by American Home Products were Pondimin and Redux, or dexfenfluramine.
American Home made fenfluramine, the fen in the fen-phen combination and gave the drug a brand name of Pondimin.
American Home Products sold the fen half of the combination under the brand name Pondimin, and made Pondimin's chemical cousin Redux.
American Home Products has agreed to pay $3.75 billion to settle thousands of lawsuits filed nationwide by people claiming health problems due to the company's once popular fen-phen diet drug combination, the company announced today.
In a major step toward resolving health claims against the diet drug combination fen-phen, drug maker American Home Products said just 1 percent of the drug's users have opted out of a multibillion dollar settlement.
More than 9,000 lawsuits have been filed against American Home Products, maker of fenfluramine,
